Key result
Micronutrient supplementation shows inconsistent cardiovascular benefits and fails to support universal CVD prevention.
Why the study?
The complex relationships between micronutrient status and cardiovascular disease outcomes are not fully understood, and evidence on supplementation benefits is inconsistent.
Does micronutrient supplementation or optimal dietary intake prevent cardiovascular disease or improve cardiovascular outcomes in human populations?
Systematic Review
Does micronutrient supplementation or optimal dietary intake prevent cardiovascular disease or improve cardiovascular outcomes in human populations?
While micronutrient deficiencies are linked to increased cardiovascular risk, current evidence does not support universal supplementation, highlighting the necessity for targeted, personalized approaches.
Answers are grounded in this paper and cite their sources.
Does not support universal micronutrient supplementation for CVD prevention; challenges observational associations and leaves targeted strategies open for study.
Cardiovascular disease (CVD) is a leading cause of global mortality, accounting for approximately 17.3 million deaths annually. The antioxidant effects of certain micronutrients may play a role in CVD prevention. This systematic review critically evaluates the evidence on antioxidant vitamins (C, E, carotenoids), B-complex vitamins, vitamin D, trace minerals (iron, copper, zinc, selenium), and electrolytes (sodium, potassium, magnesium, calcium) in cardiovascular health. This scoping review with narrative synthesis was informed by PRISMA principles. PubMed, Scopus, Cochrane Library, and Google Scholar were searched (1980-2024) for English-language human studies on micronutrients and cardiovascular outcomes. Study selection involved screening, full-text review, and snowballing. Quality was assessed through critical appraisal. Data were synthesised thematically. Approximately 70 key studies were included from over 200 identified references. Antioxidant vitamins show inconsistent benefits, with some cohorts demonstrating 27-47% risk reductions despite null RCT results. Vitamin D deficiency (30-50% prevalence) is consistently associated with CVD risk, though supplementation trials are mixed. B-vitamins improve endothelial function via homocysteine reduction. Trace minerals demonstrate biphasic relationships, where both deficiency and overload increase CVD risk. Electrolyte balance, particularly the sodium-potassium ratio, critically determines blood pressure and cardiovascular outcomes. Current evidence does not support universal supplementation. The complex relationships between micronutrient status and CVD outcomes underscore the need for personalized approaches.
No takes yet. Share an insight, caveat, or question.
Iyidobi et al. (2026) conducted a systematic review in Cardiovascular disease. Micronutrients (vitamins, trace minerals, and electrolytes) vs. Placebo, standard care, or adequate micronutrient status was evaluated on Cardiovascular outcomes (CVD risk, mortality, blood pressure). Micronutrient supplementation shows inconsistent cardiovascular benefits—despite observational cohorts demonstrating up to 47% risk reductions—ultimately indicating that current evidence does not support universal supplementation for cardiovascular disease prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: